Literature DB >> 27159763

Patient-Health Care Provider Conversations About Prenatal Genetic Screening: Recommendation or Personal Choice.

Laura C Colicchia1, Cynthia L Holland, Jill A Tarr, Doris M Rubio, Scott D Rothenberger, Judy C Chang.   

Abstract

OBJECTIVE: To assess how obstetric health care providers counsel patients regarding prenatal genetic screening and how these conversations influence patients' screening decisions.
METHODS: This cohort study analyzed transcripts and audio recordings of 210 first prenatal visits collected as part of a larger study on patient-provider communication. Conversations were coded in an iterative process to determine compliance with American College of Obstetricians and Gynecologists (College) prenatal genetic screening recommendations and to identify recurrent themes. χ, nonparametric tests, and logistic regression were used to determine the effects of discussion elements on screening decisions. Qualitative analysis was performed for genetic screening content.
RESULTS: The study included 210 patients and 45 health care providers. Health care providers offered genetic screening at 90% of visits; 78% of women chose genetic screening. Few conversations (1.5%) included all College-recommended topics. Inclusion of College-recommended topics did not affect women's screening choices. Conversations about screening for fetal aneuploidy lasted 1.5 minutes on average (range 0.12-7.05 minutes). Recurrent themes identified included clarifying that screening results are not diagnostic (51% of conversations), emphasizing that screening is a personal choice (45% of conversations), and discussing how a woman might use genetic screening results to guide decisions about diagnostic testing or termination (37% of conversations). Health care providers described screening results as "high or low risk" in 67% of conversations discussing risk and quantitatively (ie, 1 in 100 [1%]) in 33%.
CONCLUSION: Although the majority of patients were offered and underwent screening, most health care providers' counseling did not adhere to College recommendations.

Entities:  

Mesh:

Year:  2016        PMID: 27159763      PMCID: PMC4879044          DOI: 10.1097/AOG.0000000000001433

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  7 in total

1.  Patients' Knowledge of Prenatal Screening for Trisomy 21.

Authors:  Michal Sheinis; Kira Bensimon; Amanda Selk
Journal:  J Genet Couns       Date:  2017-07-14       Impact factor: 2.537

2.  Implementing Group Prenatal Counseling for Expanded Noninvasive Screening Options.

Authors:  Betsy L Gammon; Laura Otto; Myra Wick; Kristy Borowski; Megan Allyse
Journal:  J Genet Couns       Date:  2017-12-15       Impact factor: 2.537

3.  OB/GYN residents' training, attitudes, and comfort level regarding genetics.

Authors:  Anastasia Kathrens-Gallardo; Lauren Propst; Edward Linn; Rachel Pothast; Catherine Wicklund; Aishwarya Arjunan
Journal:  J Assist Reprod Genet       Date:  2021-09-13       Impact factor: 3.412

4.  "Anything above marijuana takes priority": Obstetric providers' attitudes and counseling strategies regarding perinatal marijuana use.

Authors:  Cynthia L Holland; Michelle Abena Nkumsah; Penelope Morrison; Jill A Tarr; Doris Rubio; Keri L Rodriguez; Kevin L Kraemer; Nancy Day; Robert M Arnold; Judy C Chang
Journal:  Patient Educ Couns       Date:  2016-06-04

5.  Pregnant Hispanic women's views and knowledge of prenatal genetic testing.

Authors:  Robin L Page; Christina Murphey; Yahyahan Aras; Lei-Shih Chen; Ryan Loftin
Journal:  J Genet Couns       Date:  2021-01-26       Impact factor: 2.537

6.  Prenatal Genetic Screening and Diagnostic Testing: Assessing Patients' Knowledge, Clinical Experiences, and Utilized Resources in Comparison to Provider's Perceptions.

Authors:  Arlin Delgado; Jay Schulkin; Charles J Macri
Journal:  AJP Rep       Date:  2022-02-04

7.  Service provision of non-invasive prenatal testing for Down syndrome in public and private healthcare sectors: a qualitative study with obstetric providers.

Authors:  Olivia Miu Yung Ngan; Huso Yi; Shenaz Ahmed
Journal:  BMC Health Serv Res       Date:  2018-09-21       Impact factor: 2.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.